Collaboration on Reagents for Biodectection
By Biotechdaily staff writers
Posted on 05 Nov 2002
A collaboration to develop and sell reagents to detect biothreat agents has been announced by Cepheid (Sunnyvale, CA, USA) and Applied Biosystems Group (Foster City, CA, USA). Posted on 05 Nov 2002
The reagents will be used with Cepheid's GeneXpert system and cartridges and be directed to the biologic detection system (BDS) currently being developed for potential deployment within United States Postal Service (USPS) mail sorting facilities by a consortium led by Northrop Grumman Corporation, which includes Cepheid. Additional terms of the agreement were not disclosed.
The combination of Applied Biosystems' reagent development capability and extensive experience in the field of real-time DNA testing will strongly complement Cepheid's expertise in developing real-time genetic testing systems,” said Tom Gutshall, chairman of Cepheid. "Cepheid's unique GeneXpert system and test cartridges enable the benefits of genetic testing to be taken to the point of need, such as in a USPS facility, advancing our nation's ability to rapidly and precisely identify the presence of biothreat agents.”
Related Links:
Cepheid
Applied Biosystems
Gold Member
Hematology Analyzer
Medonic M32B
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Clinical Chemistry System
P780
